跳至主要内容
临床试验/RBR-5539cm
RBR-5539cm尚未招募2 期

Randomized clinical trial of the use of amitriptyline for the prevention of neuropathic pain in patients with leprosy neuritis

Fundação Oswaldo Cruz0 个研究点开始时间: 2020年3月16日最近更新:
适应症

试验速览

阶段
2 期
状态
尚未招募

研究概览

简要总结

暂无简介。

研究设计

研究类型
Intervention

入排标准

年龄范围
18Y 至 —(—)

入选标准

  • The study will include patients older than 18 years; with a clinical diagnosis of neuritis; confirmed by electroneuromyography; registered at the service and diagnosed with neuritis; from February 2020 to January 2022.

排除标准

  • Patients diagnosed with neuropathic pain;Patients with known contraindications to the use of amitriptyline: ischemic heart,disease, cardiac arrhythmia, glaucoma and / or history of urinary retention in men;Patients with concomitant leprous nodular; erythema being treated with thalidomide;Patient with previous use ofamitriptyline and or neuropathic pain;Patient with cognitive impairment;Pregnancy or breastfeeding;Prophylactic use of amitriptyline in a previous episode of neuritis, that is, the patient will only be included once

研究者

相似试验